Abstract
This study aimed to identify predictors for unfavorable disease course and clinical and visual outcomes in pediatric patients with idiopathic intracranial hypertension (IIH). Employing a multi-tiered approach, we retrospectively analyzed clinical, ophthalmic, and neuroimaging data from patients diagnosed with IIH between 2003 and 2021. Of the 97 patients included, 56 (58%) were females. The median age was 12 years [Interquartile range (IQR) 9, 14], and the median follow-up time was 39.0 months (IQR 14.8, 90.9). Forty-two (43%) patients had an unfavorable disease course, 28 (29%) had persistence of headache at last follow-up, and 16 (18%) had a poor visual outcome, most of them with mild visual disturbances. Poor visual outcome was more common in females compared to males [16/47 (34%) vs. 0/39, p < 0.001)]. On multivariate regression analysis, female sex and disease recurrence were significantly associated with poor visual outcomes (OR: 18.5, CI:1.3–270, P = 0.03, and OR: 5.1, CI: 1.2–22.5, P = 0.03, respectively). Patients with persistent headaches exhibited lower incidence of papilledema, lower opening pressure, and fewer neuroimaging markers indicating elevated intracranial pressure.
Conclusions: This study provides insights into predictive factors for an unfavorable disease course, persistent headaches, and poor visual outcomes in patients with childhood IIH. Patients with persistent headaches may have a variant of a chronic pain syndrome warranting a different therapeutic approach.
What is Known: • Childhood-onset Idiopathic Intracranial hypertension (IIH) is a heterogenous disease. The knowledge on disease trajectory and long-term outcomes and its predictors is limited. | |
What is New: • A higher opening pressure and factors suggestive of the metabolic syndrome predict an unfavorable disease course whereas female sex and disease recurrence are significantly associated with poor visual outcomes • A third of the patients diagnosed with IIH experience ongoing headaches despite achieving favorable visual outcomes. This subset, characterized by lower disease-severity indicators at onset may represent a distinct subgroup warranting a different therapeutic approach |
Similar content being viewed by others
Availability of data and materials
All of the material is owned by the authors and is available for consultation if required.
Abbreviations
- BMI:
-
Body mass index
- CSF:
-
Cerebrospinal fluid
- ICP:
-
Intracranial hypertension
- IIH:
-
Idiopathic intracranial hypertension
- LP:
-
Lumbar puncture
- OA:
-
Optic atrophy
- OCT:
-
Optical coherence tomography
- ON:
-
Optic neuropathy
- OP:
-
Opening pressure
- RNFL:
-
Retinal nerve fiber layer
- VF:
-
Visual field
References
Dandy WE (1937) Intracranial pressure without brain tumor: diagnosis and treatment. Ann Surg 106(4):492–513
Corbett MPMJJ (1983) Cerebrospinal fluid pressure in normal obese subjects and patients with pseudotumor cerebri. Neurology 33(10):1386–1388
Smith JL (1985) Whence pseudotumor cerebri? J Clin Neuroophthalmol 5(1):55–56
Markey KA, Mollan SP, Jensen RH, Sinclair AJ (2016) Understanding idiopathic intracranial hypertension : mechanisms, management, and future directions. Lancet Neurol 15(1):78–91. https://doi.org/10.1016/S1474-4422(15)00298-7
Salpietro V et al (2012) Idiopathic intracranial hypertension : a unifying neuroendocrine hypothesis through the adrenal-brain axis. Neuroendocrinol Lett 33(6):101–105
Kerty E et al (2013) Is the brain water channel aquaporin-4 a pathogenetic factor in idiopathic intracranial hypertension ? Results from a combined clinical and genetic study in a Norwegian cohort. Acta Ophthalmol 91:88–91
McGeeney BE, Friedman DI (2014) Pseudotumor cerebri pathophysiology. Headache 54(3):445–458
Ekizoglu E, Ic S, Tuzun E, Birisik O (2012) Aquaporin-4 antibodies are not present in patients with idiopathic intracranial hypertension. Cephalagia 32(3):198–202
Matthews Y et al (2017) Pseudotumor cerebri syndrome in childhood : incidence, clinical profile and risk factors in a national prospective population-based cohort study. Arch Dis Child 102:715–721
Brara SM, Koebnick C, Porter AH, Langer-gould A (2012) Pediatric idiopathic intracranial hypertension and extreme childhood obesity. J Pediatr 161(4):602–607
Friedman DI, Liu GT, Digre KB (2013) Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and children. Am Acad Neurol 82(13):1159–1165. https://doi.org/10.1212/WNL.0b013e3182a55f17
Avery RA (2014) Interpretation of lumbar puncture opening pressure measurements in children. J Neuro-Ophthalmology 34(3):284–287
Decubitus F, Measured OP, Position F (1994) Lumbar cerebrospinal lateral fluid decubitus pressure measured in a flexed position in children. Pediatrics 93(4):622–623
Avery RA, Shah SS, Licht DJ, Seiden JA (2010) Reference range for cerebrospinal fluid opening pressure in children. N Engl J Med 363:891–893
Chagot C, Blonski M, Machu J, Bracard S, Lacour J, Richard S (2017) Idiopathic intracranial hypertension : prognostic factors and multidisciplinary management. J Obes
Wall M et al (2015) Risk factors for poor visual outcome in patients with idiopathic intracranial hypertension. Am Acad Neurol 85:799–805
Wall M, Thurtell MJ, Idiopathic N (2017) Optic disc haemorrhages at baseline as a risk factor for poor outcome in the Idiopathic Intracranial Hypertension Treatment Trial. Br J Ophthalmol 101:1256–1260
Rush JA (1980) Pseudotumor cerebri: clinical profile and visual outcome in 63 patients. Mayo Clin Proc 55(9):541–546
Mollan SP, Ali F, Hassan-smith G, Bot H, Friedman DI, Sinclair AJ (2016) Evolving evidence in adult idiopathic intracranial hypertension: pathophysiology and management. Gen Neurol 87:982–992
Chen JJ et al (2015) Causes and prognosis of visual acuity loss at the time of initial presentation in idiopathic intracranial hypertension. Invest Ophthalmol Vis Sci 56:3850–3859
Gospe SM, Bhatti MT, El-Dairi MA (2016) Anatomic and visual function outcomes in paediatric idiopathic intracranial hypertension. Br J Ophthalmol 100(4):505–509
Takkar A et al (2018) Clinical and neuro-ophthalmologic predictors of visual outcome in idiopathic intracranial hypertension. Neuro-Ophthalmology. https://doi.org/10.1080/01658107.2017.1400570
Ko MW, Liu GT (2010) Pediatric idiopathic intracranial hypertension (pseudotumor cerebri). Horm Res Paediatr 74(6):381–389
Cinciripini GS, Donahue S, Borchert MS (1999) Idiopathic intracranial hypertension in prepubertal pediatric patients: characteristics, treatment, and outcome. Am. J. Ophthalmol. 127(2):178–182
Sheldon CA et al (2016) Pediatric idiopathic intracranial hypertension age, gender, and anthropometric features at diagnosis in a large, retrospective, multisite cohort. Am Acad Ophthalmol 1–8
Hamedani AG et al (2018) Headache characteristics in children with pseudotumor cerebri syndrome, elevated opening pressure without papilledema, and normal opening pressure: a retrospective cohort study. Headache 58(9):1339–1346
Agraz D, Morgan LA, Jain SF, Suh DW (2019) Clinical features of pediatric idiopathic intracranial hypertension. Clin Ophthalmol 13:881–886. https://doi.org/10.2147/OPTH.S183087
Beres SJ et al (2018) Clinical and prognostic significance of cerebrospinal fluid opening and closing pressures in pediatric pseudotumor cerebri syndrome. Pediatr Neurol 83:50–55
Ravid S, Shahar E, Schif A, Yehudian S (2015) Visual outcome and recurrence rate in children with idiopathic intracranial hypertension. J Child Neurol 30(11):1448–1452
Frisén L (1982) Swelling of the optic nerve head: a backstage view of a staging scheme. J Neurol Neurosuregy Psychiatry 45:13–18
Stiebel-kalish H, Kalish Y, Lusky M, Gaton DAND, Ehrlich R, Shuper A (2006) Puberty as a risk factor for less favorable visual outcome in idiopathic intracranial hypertension. Adv Tech Stand Neurosurg 30:279–284
Agarwal A et al (2017) Predictors of poor visual outcome in patients with Idiopathic Intracranial Hypertension (IIH): an ambispective cohort study. Clin Neurol Neurosurg 159(707):13–18. https://doi.org/10.1016/j.clineuro.2017.05.009
Yri HM, Rönnbäck C, Wegener M, Hamann S, Jensen RH (2014) The course of headache in idiopathic intracranial hypertension: a 12-month prospective follow-up study. Eur J Neurol 21(12):1458–1464
Yri HM, Wegener M, Sander B, Jensen R (2012) Idiopathic intracranial hypertension is not benign: a long-term outcome study. J Neurol 259(5):886–894. https://doi.org/10.1007/s00415-011-6273-9
Gilchrist R, Tutz G, Firth D, Fahrmeir L, Francis B (1992) Bias reduction, the Jeffreys prior and GLIM. Advances in GLIM and Statistical Modelling: Proceedings of the GLIM 92 Conference, Munich. Springer, pp 91–100
Kesler A, Fattal-valevski A (2002) Idiopathic intracranial hypertension in the pediatric population. J Child Neurol 17:745–748
Bassan H, Berkner L, Stolovitch C, Kesler A (2008) Asymptomatic idiopathic intracranial hypertension in children. Acta Neurol Scand 118(4):251–255
Malem A, Sheth T (2021) Paediatric Idiopathic Intracranial Hypertension ( IIH )— A review. Life 11:632
Margeta MA, Buckley EG, El-dairi MA (2015) Low cerebrospinal fluid protein in prepubertal children with idiopathic intracranial hypertension. J AAPOS 19(2):135–139
Athappilly G, García-Basterra I, Machado-Miller F, Hedges TR, Mendoza-Santiesteban C, Vuong L (2019) Ganglion cell complex analysis as a potential indicator of early neuronal loss in idiopathic intracranial hypertension. Neuro-Ophthalmology 43(1):10–17
Nogueira PF et al (2021) Association between optical coherence tomography measurements and clinical parameters in idiopathic intracranial hypertension. J Ophthalmol
Biousse V, Szewka AJ, Bruce BB, Newman NJ (2013) Idiopathic intracranial hypertension: relation between obesity and visual outcomes. J Neuroophthalmol 33(1):4–8
Pollak L, Zohar E, Glovinsky Y, Huna-Baron R (2013) Reevaluation of presentation and course of idiopathic intracranial hypertension - a large cohort comprehensive study. Acta Neurol Scand 127(6):406–412
İstanbul İÜ, Fakültesi T, Dalı NA, Baykan B, Ekizoğlu E, Altiokka G (2015) An update on the pathophysiology of idiopathic intracranial hypertension alias pseudotumor cerebri İdiyopatik intrakraniyal hipertansiyonun-diğer adıyla psödotümör serebrinin-patofizyolojisi üzerine bir güncelleme Özet. AĞRI 27(2):63–72
Owler BK et al (2005) Cranial venous outflow obstruction and pseudotumor Cerebri syndrome. Adv Tech Stand Neurosurg 30:107–174. https://doi.org/10.1007/3-211-27208-9_4
Westgate CSJ et al (2021) Systemic and adipocyte transcriptional and metabolic dysregulation in idiopathic intracranial hypertension. JCI Insight 6(10):1–16
Petrus P et al (2017) Depot-specific differences in fatty acid composition and distinct associations with lipogenic gene expression in abdominal adipose tissue of obese women. Int J Obes 41:1295–1298
Mph ACT, Bhatti MT, El-dairi MA (2017) Bruch’s membrane opening on optical coherence tomography in pediatric papilledema and pseudopapilledema. J AAPOS 22(1):38–43.e3
Ekizoglu E, Baykan B, Orhan EK, Ertas M (2012) The analysis of allodynia in patients with idiopathic intracranial hypertension. Cephalagia 32:1049–1058
Mollan SP, Olivia F, Mres G, Sinclair AJ (2021) Headache attributed to idiopathic intracranial hypertension and persistent post- idiopathic intracranial hypertension headache : a narrative review. Headache 61:808–816
Hulens M, Rasschaert R, Vansant G, Stalmans I, Bruyninckx F, Dankaerts W (2018) The link between idiopathic intracranial hypertension, fibromyalgia, and chronic fatigue syndrome: Exploration of a shared pathophysiology. J Pain Res 11:3129–3140
De Simone R, Sansone M, Bonavita V (2020) Headache in idiopathic intracranial hypertension. A CGRP-dependent head pain? Neurol Sci 41:417–421. https://doi.org/10.1007/s10072-020-04641-w
Yiangou A et al (2021) Erenumab for headaches in idiopathic intracranial hypertension: A prospective open-label evaluation. Headache 61(1):157–169
Lim MJ, Pushparajah K, Jan W, Calver D, Lin J-P (2010) Magnetic resonance imaging changes in idiopathic intracranial hypertension in children. J Child Neurol 31(3):373–380
Görkem SB, Do S (2014) MR imaging findings in children with pseudotumor cerebri and comparison with healthy controls. Childs Nerv Syst 25(3):294–299
Author information
Authors and Affiliations
Contributions
All authors contributed to the study conception and design. Material preparation, data collection and analysis were performed by NS, AB, AM, ITL, and MHK. The first draft of the manuscript was written by NS and MHK and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Ethical approval
The study was approved by the Internal Review Board of the Tel Aviv Sourasky Medical Center. As the case recruitment was conducted retrospectively, obtaining informed consent was deemed unnecessary.
Conflict of interest
The authors have no potential, perceived, or real conflict of interest to disclose. This work was previously presented as an abstract or poster.
Additional information
Communicated by Peter de Winter
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Senderowich, N., Bachar-Zipori, A., Mitelpunkt, A. et al. Predictors of disease course and long-term outcomes of idiopathic intracranial hypertension in children and adolescents. Eur J Pediatr 182, 5137–5147 (2023). https://doi.org/10.1007/s00431-023-05173-z
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00431-023-05173-z